email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1516 - 1530
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
InnoCare Approved to Launch BTK Inhibitor for Three Indications in China
$5.00
Available
Ascletis Doses First Person in US Trial of Novel NASH Treatment
$5.00
Available
Medbanks Closes $305 Million Financing for China Oncology Mega-Data
$5.00
Available
Chi-Med Approved to Market Surufatinib for Neuroendocrine Tumors
$5.00
Available
DXY.cn Raises $500 Million for On-line Physician Support and Healthcare Services
$5.00
Available
Zai Lab In-licenses Novel EGFR Inhibitor in $233 Million Deal
$5.00
Available
Oceanpine Raises $400 Million for China-US Technology Companies
$5.00
Available
Synyi Closes $61 Million Round for AI-based Medical Data Analysis
$5.00
Available
China Adds 119 New Drugs to NRDL after 51% Price Cuts
$5.00
Available
Hasten Bio Pays $322 Million for China Rights to Five Takeda Drugs
$5.00
Available
Transcenta of China Raises $105 Million to Develop Antibody Drugs
$5.00
Available
CASI Granted Breakthrough Status in China for CD19 CAR-T Therapy
$5.00
Available
WuXi Biologics Pays $183 Million to Acquire Bayer German Manufacturing Facility
$5.00
Available
3E Bioventures Forms China JV for Peripheral Neuropathy Therapy with Regenacy
$5.00
Available
Ascentage's Bcl-xL Inhibitor Starts US Trials for Macular Edema
$5.00
Available